• About Us
  • Team
  • News
  • For Patients
  • Contact
  • About Us
  • Team
  • News
  • For Patients
  • Contact

CFN

Home » Home » CFN

Recent Posts
  • Cardurion Pharmaceuticals Announces Dosing of Patients in CARDINAL-HF, a Phase 2 Clinical Trial of its PDE9 inhibitor in Heart Failure
  • Cardurion Pharmaceuticals Enhances Leadership Team with Appointment of Marcia Moore as Chief Operating Officer
  • Cardurion Pharmaceuticals Announces Investment of up to $300 Million from Bain Capital
  • Cardurion Pharmaceuticals Announces Appointment of Howard K. Surks, M.D., as Chief Scientific Officer and Head, Translational Medicine
  • Cardurion Pharmaceuticals Announces Appointment of Chris Morabito, M.D., as Chief Medical Officer
Recent Comments
    Archives
    • September 2022
    • February 2022
    • October 2021
    • January 2021
    • July 2020
    • April 2020
    • November 2019
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • April 2018
    • August 2017
    Categories
    • News
    Meta
    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Navigation
    • About Us
    • Team
    • News
    • For Patients
    • Contact
    Contact Us

    Cardurion Pharmaceuticals
    Email: info@cardurion.com

    Proudly Built By

    Bellwether Digital